Phase 1 Heart Disease Trial, Recruiting NCT07551167 Sponsor: Chengdu Suncadia Medicine Co., Ltd. Condition: Heart Disease
Back to Heart Disease

Phase 1 Heart Disease Trial, Recruiting

NCT07551167
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a generally healthy man or woman between 18 and 65 years old
  • Men weigh at least 50 kg but less than 90 kg, or women weigh at least 45 kg but less than 90 kg, with a BMI between 19 and 26 kg/m²
  • Your health checks at the start of the study show no significant medical concerns
  • If you could potentially have children, you agree to use effective birth control from joining the trial until at least one week after your last dose, and agree not to donate sperm or eggs during this time

Who may not be able to join:

  • You have a history of, or currently have, serious illness affecting major body systems that could affect the trial results
  • You have had a serious infection, significant injury, or major surgery in the last 3 months, or have surgery planned during the trial
  • You have donated blood or lost a large amount of blood (400 mL or more) in the last 3 months, received a blood transfusion in the last 4 weeks, or plan to donate blood during the trial
  • You have a history of drug misuse or dependence, or your drug screening test comes back positive
  • You have taken part in another clinical trial in the last 3 months, are currently in one, or the previous trial drug has not fully cleared your system yet (confirm with trial site)
  • You have smoked 5 or more cigarettes per day in the last 4 weeks, or are unable to avoid smoking during the trial
  • You test positive for Hepatitis B, Hepatitis C, HIV, or syphilis at screening
  • You have special dietary needs that would stop you from following the standard meals provided during the trial
  • You have difficulty swallowing or with having blood taken through a vein, or cannot tolerate having blood taken frequently
  • The trial researchers decide there is another reason you would not be suitable for the trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +86 0518-82342973

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Chengdu Suncadia Medicine Co., Ltd.
Registry
ClinicalTrials.gov
Start date
20 May 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of adverse event (AE); Incidence of serious adverse event (SAE)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov